Any feedback?
Literature summary for 1.13.11.31 extracted from
- Characterization of mice ubiquitously overexpressing human 15-lipoxygenase-1 effect of diabetes on peripheral neuropathy and treatment with menhaden oil (2021), J. Diabetes Res., 2021, 5564477 .
Application
| Application | Comment | Organism |
|---|---|---|
| medicine | when treating type 2 diabetic wild-type mice and transgenic mice ubiquitously overexpressing 15-LOX-1 with menhaden (fish) oil, there is a trend for the severity of diabetic peripheral neuropathy-related deficits to be less in the diabetic transgenic mice compared to the diabetic wild-type mice. Treating diabetic wild-type and transgenic mice with menhaden oil improves the diabetic peripheral neuropathy-related endpoints with a trend for greater improvement or protection by menhaden oil observed in the diabetic transgenic mice | Homo sapiens |
Organism
| Organism | UniProt | Comment | Textmining |
|---|---|---|---|
| Homo sapiens | P16050 | cf. EC 1.13.11.33, EC 1.13.11.12 | - |
Use of this online version of BRENDA is free under the CC BY 4.0 license. See terms of use for full details.
Release 2023.1 (January 2023)
Legal
Curated at
Member of
